Nasus Pharma Ltd. Ordinary Shares (NSRX) analyst actions
Rating and price-target actions on NSRX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the NSRX overview →
1 measured NSRX analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Nasus Pharma Announces Initiation of Phase 2 Clinical Study of NS002 with First Participant Dosed | Press release | +0.86% | -3.57% |
Keep exploring
More NSRX: earnings → · SEC filings → · NSRX overview →